Ignite Creation Date:
2025-12-25 @ 12:58 AM
Ignite Modification Date:
2025-12-27 @ 12:37 PM
Study NCT ID:
NCT06110793
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2023-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-29
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-26
First Submit QC Date:
None
Study First Post Date:
2023-11-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-12
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED